Market Overview

The global clinical nutrition market was valued at USD 55.8 Billion in 2024 and is projected to reach USD 104.6 Billion by 2033, expanding at a CAGR of 7.2% during 2025-2033. Market growth is driven by increasing chronic diseases, aging populations, rising awareness of nutrition's role in healthcare, technological advances in personalized and medical nutrition, and changing dietary habits.

Study Assumption Years

  • Base Year: 2024
  • Historical Years: 2019-2024
  • Forecast Period: 2025-2033

Clinical Nutrition Market Key Takeaways

  • The global clinical nutrition market size was USD 55.8 Billion in 2024.
  • It is forecasted to grow at a CAGR of 7.2% during 2025-2033.
  • The forecast period is from 2025 to 2033.
  • Market drivers include collaborations among key players and increased adoption of functional foods.
  • The rising geriatric population and technological healthcare advancements are key trends.
  • Asia Pacific dominates the market due to chronic disease prevalence.
  • Regulatory challenges and high costs hinder growth; however, personalized nutrition and digital technologies offer opportunities.

Sample Request Link: 

https://www.imarcgroup.com/clinical-nutrition-market/requestsample

Market Growth Factors

The growth in prevalence of chronic diseases and the growing worldwide geriatric population are the major factors responsible for the growth of the clinical nutrition market. Geriatric population has poor nutrient absorption and slow metabolism. According to World Health Organization (WHO), globally, the population of 80 year and older will be more than triple to reach around 426 million by 2050. Chronic conditions such as diabetes, cancer, osteoporosis and cardiovascular disease require specific dietary treatments in geriatric nutrition that may vary from the general population.

The rise in knowledge of the role of nutrition in health care is also driving market growth. Healthcare professionals are supporting assessing, advising on, and intervening on nutrition to improve the health of their patients. Functional foods, fortified ready-to-drink (RTD) beverages, and personalized nutrition have recorded meaningful growth as consumers seek products with functions such as immunity, digestion, and cognition. IMARC expects the global RTD beverage market to exceed US$ 402.0 Billion by 2032.

Personalized nutrition technology and MNT are also expected to drive growth. These technologies, such as nutrigenomics, metabolomics, wearable devices, and digital health platforms, provide tailored feedback, remote monitoring, and individualized nutritional coaching. They are also launching more proactive healthcare products in response to personal nutrition and lifestyle. For example, in November 2023, FrieslandCampina Ingredients launched Nutri Whey™ ProHeat, a heat-stable whey protein ingredient for the medical nutrition market.

Market Segmentation

Product:

  • Infant Nutrition: Represents the largest segment focusing on newborn and infant dietary requirements. Breast milk and infant formula provide essential nutrients, bioactive substances, and antibodies crucial for growth and immune function.
  • Parental Nutrition
  • Enteral Nutrition

Route of Administration:

  • Oral: Holds the largest market share, including dietary supplements, functional foods, OTC pharmaceuticals, and oral nutritional supplements available in various forms like liquids, powders, capsules, tablets, and bars.
  • Enteral
  • Parenteral

Application:

  • Cancer: Clinical nutrition aids patients undergoing chemotherapy, radiation, or surgery to maintain nutritional status and support recovery.
  • Malnutrition: Interventions address nutrient deficiencies, restore energy balance, and improve overall nutritional status.
  • Metabolic Disorders: Nutrition therapy optimizes dietary patterns to manage glucose levels, weight, and cardiovascular risks.
  • Gastrointestinal Disorders
  • Neurological Disorders
  • Others

End User:

  • Pediatric: Accounts for the largest share, with dietary needs critical for growth and development in individuals under 18 years.
  • Adults
  • Geriatric

Regional Insights

Asia Pacific dominates the clinical nutrition market with the largest share. This is driven by rapid urbanization, changing dietary habits, rising chronic disease burdens, increasing income levels, and improved healthcare access. The region also experiences a growing geriatric population, especially in India and China, where the population aged 80+ is expected to grow by approximately 279% between 2022 and 2050 according to UNFPA.

Recent Developments & News

  • On 16 February 2023, Nestlé Health Science and EraCal Therapeutics Ltd. announced a research collaboration to identify novel nutraceuticals to control food intake, combining Nestlé's nutraceutical resources with EraCal’s drug discovery platform.
  • On 3 May 2024, Danone completed the acquisition of Functional Formularies, a US-based whole foods tube feeding business, expanding its Medical Nutrition portfolio and enteral tube feeding ranges.

Key Players

  • Abbott Laboratories
  • Ajinomoto Co., Inc.
  • Baxter International Inc.
  • Danone S.A
  • Fresenius Kabi Ltd
  • Kate Farms
  • Medifood
  • Nestlé Health Science
  • Perrigo Company plc
  • Reckitt

Request For Customization:

https://www.imarcgroup.com/request?type=report&id=5995&flag=E

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302